Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of AKRO by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−1,785,586−100.0%Sold outHolders
Q3 20251,785,586$84.8M<0.1%+63,181+3.7%AddedHolders
Q2 20251,722,405$91.9M<0.1%−26,789−1.5%ReducedHolders
Q1 20251,749,194$70.8M<0.1%+189,563+12.2%AddedHolders
Q4 20241,559,631$43.4M<0.1%−11,381−0.7%ReducedHolders
Q3 20241,571,012$45.1M<0.1%−48,027−3.0%ReducedHolders
Q2 20241,619,039$38.0M<0.1%+199,732+14.1%AddedHolders
Q1 20241,419,307$35.9M<0.1%+253,062+21.7%AddedHolders
Q4 20231,166,245$27.2M<0.1%+62,939+5.7%AddedHolders
Q3 20231,103,306$55.8M<0.1%+278,599+33.8%AddedHolders
Q2 2023824,707$38.5M<0.1%+158,780+23.8%AddedHolders
Q1 2023665,927$25.5M<0.1%+32,547+5.1%AddedHolders
Q4 2022633,380$34.7M<0.1%+110,091+21.0%AddedHolders
Q3 2022523,289$17.8M<0.1%+55,304+11.8%AddedHolders
Q2 2022467,985$4.42M<0.1%+24,512+5.5%AddedHolders
Q1 2022443,473$6.29M<0.1%+26,792+6.4%AddedHolders
Q4 2021416,681$8.81M<0.1%+38,988+10.3%AddedHolders
Q3 2021377,693$8.44M<0.1%+15,115+4.2%AddedHolders
Q2 2021362,578$8.99M<0.1%+98,095+37.1%AddedHolders
Q1 2021264,483$7.67M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.